Osteoporosis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Refer to the 2017 clinical guidelines on the diagnosis and treatment of osteoporosis in China, which meets one of the following three criteria: 1. Hip or vertebral fragility fractures; 2. The BMD (bone mass density) of axial bones or the distal third of the tibia, measured by dual X-ray absorptiometry (DXA), with a T-score of = 2.5 SD; 3. Low bone mass, which was defined as 2.5 SD < T-score = 1.0 SD +fragility fractures of the proximal humerus, pelvis or distal forearm.
Exclusion criteria
Exclusion criteria: 1. Patients complicated with clinically significant cardiovascular, renal, hepatic disease; 2. Patients with mental illness or without self-knowledge; 3. Patients with secondary osteoporosis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Berg balance scale;Visual analogue scales score;25-hydroxycholecalciferol;procollagen type I N-terminal propeptide(PINP);prevalence of osteoporosis;Time up and go test;TCM Syndrome Therapeutic Evaluation Scale;Osteoporosis knowledge assessment;QUALEFFO 41;Serum type I collagen amino terminal peptide (Serum CTX-I);Bone mineral density; | — |
Countries
China
Contacts
WenZhou Hospital of Traditional Chinese Medicine